Mammography Systems Market By Product (Digital System, Analog System); By Technology (2D, 3D); By End User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Others); By Region – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032
Global Mammography Systems Market size was valued at USD 1,746.1 million in 2018 to USD 2,649.7million in 2024 and is anticipated to reach USD 4,649.3 million by 2032, at a CAGR of 7.31% during the forecast period.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2023
Base Year
2024
Forecast Period
2025-2032
Mammography Systems Market Size 2024
USD 2,649.7 Million
Mammography Systems Market, CAGR
7.31%
Mammography Systems Market Size 2032
USD 4,649.3 Million
The Global Mammography Systems Market is shaped by key players including Fujifilm Holdings Corporation, GE HealthCare, Hologic Inc., Siemens Healthineers, Koninklijke Philips N.V., Canon Medical Systems, Carestream Health, Agfa-Gevaert Group, and Metaltronica SpA. These companies maintain strong positions through advanced product portfolios, continuous innovation in digital and 3D tomosynthesis systems, and extensive global distribution networks. Strategic investments in artificial intelligence integration and low-dose imaging technologies further enhance their competitiveness. Regionally, North America led the market in 2024 with a 34.5% share, driven by robust healthcare infrastructure, favorable reimbursement policies, and high adoption of advanced diagnostic systems.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
The Global Mammography Systems Market grew from USD 1,746.1 million in 2018 to USD 2,649.7 million in 2024 and will reach USD 4,649.3 million by 2032.
Digital systems dominated with 82% share in 2024, supported by higher imaging accuracy, low radiation exposure, and government-backed digital screening initiatives.
3D mammography led with 61% share in 2024, driven by earlier cancer detection, reduced false positives, and clinical guidelines recommending advanced tomosynthesis.
Hospitals accounted for the largest share of 47% in 2024, benefiting from higher patient inflow, advanced diagnostic facilities, and integrated treatment pathways.
North America held the top position with a 5% market share in 2024, fueled by advanced infrastructure, favorable reimbursement, and strong adoption of 3D mammography.
Market Segment Insights
By Product
In the Global Mammography Systems Market, the digital system segment accounted for nearly 82% share in 2024, establishing clear dominance over analog systems. Digital systems are preferred due to higher imaging accuracy, lower radiation exposure, and advanced image storage capabilities that support AI-based diagnostics. Continuous upgrades in full-field digital mammography and government programs promoting digital screening further drive this segment, while analog systems maintain limited use in resource-constrained regions.
By Technology
The 3D mammography segment led the market with about 61% share in 2024, surpassing traditional 2D technology. The strong adoption of 3D systems is driven by their ability to detect cancers earlier, reduce false positives, and improve diagnostic confidence. Rising investment in tomosynthesis, alongside clinical guidelines recommending 3D adoption, reinforces its leadership, while 2D technology continues to serve basic screening needs in developing healthcare setups.
For instance, GE HealthCare launched its Senographe Pristina with AI-enabled 3D tomosynthesis in Europe, aimed at reducing recall rates and enhancing image clarity in dense breast tissue.
By End User
The hospital segment dominated the Global Mammography Systems Market with a 47% share in 2024, supported by large-scale infrastructure and advanced diagnostic facilities. Hospitals benefit from higher patient inflow, integrated imaging centers, and the ability to conduct both screening and follow-up treatments. Diagnostic imaging centers followed closely, driven by outpatient demand for faster and cost-effective procedures, while ambulatory surgical centers and other facilities accounted for smaller shares, reflecting their niche roles in specific patient care settings.
For instance, Siemens Healthineers received FDA clearance for its Mammomat B.brilliant mammography platform, designed for high-throughput hospital environments.
Key Growth Drivers
Rising Breast Cancer Prevalence
The increasing incidence of breast cancer worldwide is a major growth driver for the Global Mammography Systems Market. With breast cancer being one of the leading causes of mortality among women, governments and healthcare organizations emphasize early detection. This has led to large-scale screening programs, especially in developed regions, boosting the demand for mammography systems. Growing awareness campaigns, coupled with rising patient willingness to undergo preventive diagnostics, further accelerate adoption across hospitals and imaging centers.
For instance, in April 2024, the United States Preventive Services Task Force updated its guidelines to recommend biennial mammography screening for women aged 40 to 74, supporting expanded screening programs in the U.S. and pushing hospitals to invest in advanced imaging technologies.
Technological Advancements in Imaging
Rapid technological innovations, including 3D tomosynthesis, AI-powered image interpretation, and low-dose radiation systems, are reshaping the market. These advancements significantly improve detection rates, reduce false positives, and enhance workflow efficiency for radiologists. Healthcare providers increasingly prefer advanced digital and 3D systems, which deliver more precise results compared to traditional 2D models. The integration of artificial intelligence in mammography also supports faster decision-making, making advanced technologies a core driver of adoption across both developed and emerging economies.
Government Support and Reimbursement Policies
Strong government support in the form of screening mandates, public health programs, and reimbursement policies plays a vital role in market expansion. Initiatives such as free or subsidized breast cancer screening for women above a certain age group have widened access. In the U.S. and Europe, favorable reimbursement for advanced mammography techniques like tomosynthesis has boosted utilization. Emerging economies are also increasing funding for diagnostic infrastructure, ensuring broader patient reach and driving higher adoption of mammography systems globally.
For instance, Clairity, Inc. announced plans to launch Clairity Breast, an AI tool that predicts breast cancer risk using mammograms, enabling personalized screening and preventive care for patients through hospitals and imaging centers.
Key Trends & Opportunities
Integration of AI and Machine Learning
The adoption of artificial intelligence (AI) in mammography systems is a transformative trend, offering opportunities for improved efficiency and diagnostic accuracy. AI-powered tools assist radiologists in detecting subtle abnormalities, reducing human error, and improving workflow by automating image analysis. Vendors are increasingly focusing on AI integration, enabling faster reading of mammograms and greater consistency in results. This trend is particularly relevant in regions facing radiologist shortages, positioning AI-based mammography as a key opportunity for future growth.
For instance, DeepHealth’s SmartMammo™, integrated into RadNet’s workflow, increased cancer detection rates by 21% and improved efficiency with AI-powered prioritization and instant image streaming across 230+ screening sites.
Expansion in Emerging Markets
Emerging economies across Asia Pacific, Latin America, and Africa present significant growth opportunities for mammography system providers. Rising disposable incomes, improving healthcare infrastructure, and growing awareness of early cancer detection are driving demand. Governments in these regions are also increasing investments in screening programs and partnering with private providers to expand access. As healthcare modernization continues, the uptake of digital and 3D mammography systems is expected to accelerate, making emerging markets a strategic growth frontier.
For instance, Fujifilm Healthcare launched its Amulet Innovality digital mammography system in Brazil, strengthening access to advanced breast imaging in Latin America’s largest healthcare market.
Key Challenges
High Cost of Advanced Systems
The high initial cost of advanced mammography systems, particularly 3D tomosynthesis and AI-integrated models, remains a significant challenge. Many healthcare providers in low- and middle-income regions struggle to afford such systems, limiting adoption. Even in developed markets, budget constraints in smaller hospitals and clinics can delay upgrades to newer technologies. This cost barrier slows down market penetration, especially in regions where reimbursement policies are less favorable or healthcare budgets are restricted.
Shortage of Skilled Radiologists
A global shortage of trained radiologists and technicians poses another key challenge. Effective use of mammography systems requires specialized expertise to interpret complex imaging results accurately. In many developing countries, limited availability of skilled professionals reduces the efficiency of screening programs and affects diagnostic outcomes. This shortage also places a burden on existing radiologists, leading to longer turnaround times and potential errors, which can hinder the wider adoption of advanced mammography technologies.
Regulatory and Compliance Barriers
Strict regulatory requirements for product approval and compliance increase the complexity of bringing new mammography systems to market. Manufacturers must adhere to rigorous testing and certification processes, which can delay product launches and raise development costs. Variations in regulatory standards across regions add further hurdles for global players. Additionally, compliance with patient safety and data protection regulations, especially with AI-enabled systems, adds to operational challenges for companies operating in this market.
Regional Analysis
North America
North America generated USD 478.78 million in 2018, reaching USD 721.79 million in 2024, and is forecasted to achieve USD 1,255.32 million by 2032 at a CAGR of 7.2%. The region held the largest share of 34.5% in 2024, driven by strong adoption of 3D tomosynthesis, supportive reimbursement structures, and well-established screening programs. The U.S. remains the primary contributor with advanced healthcare infrastructure, AI integration in imaging, and government-backed awareness campaigns supporting continued market leadership.
Europe
Europe was valued at USD 386.06 million in 2018, increasing to USD 574.39 million in 2024, and projected to reach USD 981.01 million by 2032 at a CAGR of 7.0%. The region accounted for 27.5% market share in 2024, supported by population-based screening initiatives and strong public healthcare systems. Countries such as Germany, France, and the UK lead adoption, while investments in digital and 3D mammography strengthen Europe’s role as the second-largest global market.
Asia Pacific
Asia Pacific stood at USD 607.29 million in 2018, rising to USD 935.44 million in 2024, and expected to reach USD 1,673.77 million by 2032, registering a CAGR of 7.6%. The region captured 28.2% share in 2024, led by China, Japan, and India. Growth is fueled by rising healthcare investments, government-supported cancer screening initiatives, and expanding private sector diagnostic infrastructure. Increasing adoption of advanced digital and 3D imaging makes Asia Pacific the fastest-growing regional market.
Latin America
Latin America recorded USD 155.58 million in 2018, rising to USD 242.22 million in 2024, and anticipated to reach USD 439.36 million by 2032 at a CAGR of 7.8%. The region accounted for 7.3% share in 2024, with Brazil as the largest market. Expanding healthcare access, public-private partnerships, and introduction of mobile mammography units are driving adoption. Rising awareness campaigns and government focus on preventive screening further support growth in Latin America.
Middle East
The Middle East market was USD 83.46 million in 2018, growing to USD 129.38 million in 2024, and forecasted to reach USD 233.40 million by 2032, at a CAGR of 7.7%. Holding a 3.9% share in 2024, the region benefits from government investment in women’s health and expanding diagnostic infrastructure. GCC nations, particularly Saudi Arabia and the UAE, lead adoption, while technological upgrades and screening awareness initiatives enhance future demand.
Africa
Africa generated USD 34.92 million in 2018, rising to USD 46.52 million in 2024, and is set to reach USD 66.49 million by 2032, growing at a CAGR of 4.6%. It accounted for 2.2% share in 2024, the lowest among regions. Limited access to diagnostic infrastructure, affordability challenges, and low awareness levels restrict widespread adoption. South Africa and Egypt remain key contributors, while mobile units and NGO-led initiatives present incremental opportunities to expand screening programs across underserved areas.
Market Segmentations:
By Product
Digital System
Analog System
By Technology
2D
3D
By End User
Hospitals
Diagnostic Imaging Centers
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa
Competitive Landscape
The Global Mammography Systems Market is highly competitive, with leading players focusing on technological innovation, strategic partnerships, and portfolio expansion to strengthen their positions. Key companies such as Fujifilm Holdings Corporation, GE HealthCare, Hologic Inc., Siemens Healthineers, Koninklijke Philips N.V., and Canon Medical Systems dominate the market with strong brand presence, advanced digital and 3D tomosynthesis solutions, and extensive global distribution networks. These firms invest heavily in research and development to integrate artificial intelligence, improve imaging accuracy, and reduce radiation exposure, catering to growing demand for early breast cancer detection. Mid-tier players like Carestream Health, Agfa-Gevaert Group, and Metaltronica SpA compete by offering cost-effective systems and expanding into emerging markets with localized solutions. Market competition is also shaped by regulatory approvals, clinical trial outcomes, and reimbursement policies, which influence adoption rates. Continuous product launches, mergers, and collaborations define the competitive landscape, creating opportunities for innovation while intensifying rivalry among global and regional participants.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In November 2024, GE HealthCare introduced the Pristina Via mammography system featuring enhanced breast screening experience and lower radiation doses across all breast thicknesses.
In 2023, Siemens Healthineers launched Mammomat B.brilliant, a mammography system with wide-angle tomosynthesis.
In April 2025, RadNet, Inc. through its DeepHealth unit, acquired iCAD, Inc. to strengthen AI-powered breast cancer detection solutions.
In February 2025, DeepHealth launched new AI-driven radiology informatics and population screening tools at the European Congress of Radiology (ECR).
Report Coverage
The research report offers an in-depth analysis based on Product, Technology, End User and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
Adoption of 3D tomosynthesis will expand due to higher accuracy in cancer detection.
Artificial intelligence integration will improve diagnostic efficiency and reduce false positives.
Emerging economies will drive demand with improving healthcare infrastructure and awareness programs.
Portable and mobile mammography units will gain traction in rural and underserved areas.
Hospitals will remain the primary end users due to comprehensive diagnostic facilities.
Diagnostic imaging centers will increase adoption to serve outpatient and preventive care demand.
Reimbursement policies and government screening initiatives will strongly influence market growth.
Strategic partnerships and collaborations will accelerate innovation and market penetration.
Cost-effective digital systems will see higher demand in developing regions.
Rising public awareness campaigns will continue to support early detection and screening adoption.
CHAPTER NO. 1 : GENESIS OF THE MARKET
1.1 Market Prelude – Introduction & Scope
1.2 The Big Picture – Objectives & Vision
1.3 Strategic Edge – Unique Value Proposition
1.4 Stakeholder Compass – Key Beneficiaries CHAPTER NO. 2 : EXECUTIVE LENS
2.1 Pulse of the Industry – Market Snapshot
2.2 Growth Arc – Revenue Projections (USD Million)
2.3. Premium Insights – Based on Primary Interviews CHAPTER NO. 3 : MAMMOGRAPHY SYSTEMS MARKET FORCES & INDUSTRY PULSE
3.1 Foundations of Change – Market Overview
3.2 Catalysts of Expansion – Key Market Drivers
3.2.1 Momentum Boosters – Growth Triggers
3.2.2 Innovation Fuel – Disruptive Technologies
3.3 Headwinds & Crosswinds – Market Restraints
3.3.1 Regulatory Tides – Compliance Challenges
3.3.2 Economic Frictions – Inflationary Pressures
3.4 Untapped Horizons – Growth Potential & Opportunities
3.5 Strategic Navigation – Industry Frameworks
3.5.1 Market Equilibrium – Porter’s Five Forces
3.5.2 Ecosystem Dynamics – Value Chain Analysis
3.5.3 Macro Forces – PESTEL Breakdown CHAPTER NO. 4 : KEY INVESTMENT EPICENTER
4.1 Regional Goldmines – High-Growth Geographies
4.2 Product Frontiers – Lucrative Product Categories
4.3 End User Sweet Spots – Emerging Demand Segments CHAPTER NO. 5: REVENUE TRAJECTORY & WEALTH MAPPING
5.1 Momentum Metrics – Forecast & Growth Curves
5.2 Regional Revenue Footprint – Market Share Insights
5.3 Segmental Wealth Flow – Product, Technology, and End User Revenue CHAPTER NO. 6 : TRADE & COMMERCE ANALYSIS
6.1. Import Analysis By Region
6.1.1. Global Mammography Systems Market Import Revenue By Region
6.2. Export Analysis By Region
6.2.1. Global Mammography Systems Market Export Revenue By Region CHAPTER NO. 7 : COMPETITION ANALYSIS
7.1. Company Market Share Analysis
7.1.1. Global Mammography Systems Market: Company Market Share
7.2. Global Mammography Systems Market Company Revenue Market Share
7.3. Strategic Developments
7.3.1. Acquisitions & Mergers
7.3.2. New Product Launch
7.3.3. Regional Expansion
7.4. Competitive Dashboard
7.5. Company Assessment Metrics, 2024 CHAPTER NO. 8 : MAMMOGRAPHY SYSTEMS MARKET – BY PRODUCT SEGMENT ANALYSIS
8.1. Mammography Systems Market Overview By Product Segment
8.1.1. Mammography Systems Market Revenue Share By Product
8.2. Digital System
8.3. Analog System CHAPTER NO. 9 : MAMMOGRAPHY SYSTEMS MARKET – BY TECHNOLOGY SEGMENT ANALYSIS
9.1. Mammography Systems Market Overview By Technology Segment
9.1.1. Mammography Systems Market Revenue Share By Technology
9.2. 2 D
9.3. 3 D CHAPTER NO. 10 : MAMMOGRAPHY SYSTEMS MARKET – BY END USER SEGMENT ANALYSIS
10.1. Mammography Systems Market Overview By End User Segment
10.1.1. Mammography Systems Market Revenue Share By End User
10.2. Hospitals
10.3. Diagnostic Imaging Centers
10.4. Ambulatory Surgical Centers
10.5. Others CHAPTER NO. 11 : MAMMOGRAPHY SYSTEMS MARKET – REGIONAL ANALYSIS
11.1. Mammography Systems Market Overview By Region Segment
11.1.1. Global Mammography Systems Market Revenue Share By Region
10.1.2. Regions
11.1.3. Global Mammography Systems Market Revenue By Region
11.1.4. Product
11.1.5. Global Mammography Systems Market Revenue By Product
11.1.6. Technology
11.1.7. Global Mammography Systems Market Revenue By Technology
11.1.8. End User
11.1.9. Global Mammography Systems Market Revenue By End User CHAPTER NO. 12 : NORTH AMERICA MAMMOGRAPHY SYSTEMS MARKET – COUNTRY ANALYSIS
12.1. North America Mammography Systems Market Overview By Country Segment
12.1.1. North America Mammography Systems Market Revenue Share By Region
12.2. North America
12.2.1. North America Mammography Systems Market Revenue By Country
12.2.2. Product
12.2.3. North America Mammography Systems Market Revenue By Product
12.2.4. Technology
12.2.5. North America Mammography Systems Market Revenue By Technology
12.2.6. End User
12.2.7. North America Mammography Systems Market Revenue By End User
12.3. U.S.
12.4. Canada
12.5. Mexico CHAPTER NO. 13 : EUROPE MAMMOGRAPHY SYSTEMS MARKET – COUNTRY ANALYSIS
13.1. Europe Mammography Systems Market Overview By Country Segment
13.1.1. Europe Mammography Systems Market Revenue Share By Region
13.2. Europe
13.2.1. Europe Mammography Systems Market Revenue By Country
13.2.2. Product
13.2.3. Europe Mammography Systems Market Revenue By Product
13.2.4. Technology
13.2.5. Europe Mammography Systems Market Revenue By Technology
13.2.6. End User
13.2.7. Europe Mammography Systems Market Revenue By End User
13.3. UK
13.4. France
13.5. Germany
13.6. Italy
13.7. Spain
13.8. Russia
13.9. Rest of Europe CHAPTER NO. 14 : ASIA PACIFIC MAMMOGRAPHY SYSTEMS MARKET – COUNTRY ANALYSIS
14.1. Asia Pacific Mammography Systems Market Overview By Country Segment
14.1.1. Asia Pacific Mammography Systems Market Revenue Share By Region
14.2. Asia Pacific
14.2.1. Asia Pacific Mammography Systems Market Revenue By Country
14.2.2. Product
14.2.3. Asia Pacific Mammography Systems Market Revenue By Product
14.2.4. Technology
14.2.5. Asia Pacific Mammography Systems Market Revenue By Technology
14.2.6. End User
14.2.7. Asia Pacific Mammography Systems Market Revenue By End User
14.3. China
14.4. Japan
14.5. South Korea
14.6. India
14.7. Australia
14.8. Southeast Asia
14.9. Rest of Asia Pacific CHAPTER NO. 15 : LATIN AMERICA MAMMOGRAPHY SYSTEMS MARKET – COUNTRY ANALYSIS
15.1. Latin America Mammography Systems Market Overview By Country Segment
15.1.1. Latin America Mammography Systems Market Revenue Share By Region
15.2. Latin America
15.2.1. Latin America Mammography Systems Market Revenue By Country
15.2.2. Product
15.2.3. Latin America Mammography Systems Market Revenue By Product
15.2.4. Technology
15.2.5. Latin America Mammography Systems Market Revenue By Technology
15.2.6. End User
15.2.7. Latin America Mammography Systems Market Revenue By End User
15.3. Brazil
15.4. Argentina
15.5. Rest of Latin America CHAPTER NO. 16 : MIDDLE EAST MAMMOGRAPHY SYSTEMS MARKET – COUNTRY ANALYSIS
16.1. Middle East Mammography Systems Market Overview By Country Segment
16.1.1. Middle East Mammography Systems Market Revenue Share By Region
16.2. Middle East
16.2.1. Middle East Mammography Systems Market Revenue By Country
16.2.2. Product
16.2.3. Middle East Mammography Systems Market Revenue By Product
16.2.4. Technology
16.2.5. Middle East Mammography Systems Market Revenue By Technology
16.2.6. End User
16.2.7. Middle East Mammography Systems Market Revenue By End User
16.3. GCC Countries
16.4. Israel
16.5. Turkey
16.6. Rest of Middle East CHAPTER NO. 17 : AFRICA MAMMOGRAPHY SYSTEMS MARKET – COUNTRY ANALYSIS
17.1. Africa Mammography Systems Market Overview By Country Segment
17.1.1. Africa Mammography Systems Market Revenue Share By Region
17.2. Africa
17.2.1. Africa Mammography Systems Market Revenue By Country
17.2.2. Product
17.2.3. Africa Mammography Systems Market Revenue By Product
17.2.4. Technology
17.2.5. Africa Mammography Systems Market Revenue By Technology
17.2.6. End User
17.2.7. Africa Mammography Systems Market Revenue By End User
17.3. South Africa
17.4. Egypt
17.5. Rest of Africa CHAPTER NO. 18 : COMPANY PROFILES
18.1. Fujifilm Holdings Corporation
18.1.1. Company Overview
18.1.2. Product Portfolio
18.1.3. Financial Overview
18.1.4. Recent Developments
18.1.5. Growth Strategy
18.1.6. SWOT Analysis
18.2. GE HealthCare
18.3. Hologic Inc.
18.4. Koninklijke Philips N.V.
18.5. Siemens Healthineers
18.6. Canon Medical Systems
18.7. Carestream Health
18.8. Agfa-Gevaert Group
18.9. Metaltronica SpA
18.10. Other Key Players
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions
What is the current market size for Global Mammography Systems Market, and what is its projected size in 2032?
The Global Mammography Systems Market was USD 2,649.7 million in 2024 and is projected to reach USD 4,649.3 million by 2032.
At what Compound Annual Growth Rate is the Global Mammography Systems Market projected to grow between 2025 and 2032?
The Global Mammography Systems Market is projected to grow at a compound annual growth rate (CAGR) of 7.31% during the forecast period from 2025 to 2032.
Which Global Mammography Systems Market segment held the largest share in 2024?
The digital system segment held the largest share of nearly 82% in 2024, driven by high imaging accuracy, low radiation exposure, and widespread adoption.
What are the primary factors fueling the growth of the Global Mammography Systems Market?
Key growth factors include rising breast cancer prevalence, technological advancements in imaging such as 3D tomosynthesis, government screening initiatives, and increasing adoption of digital diagnostic systems worldwide.
Who are the leading companies in the Global Mammography Systems Market?
Leading companies include Fujifilm Holdings Corporation, GE HealthCare, Hologic Inc., Siemens Healthineers, Koninklijke Philips N.V., Canon Medical Systems, Carestream Health, Agfa-Gevaert Group, and Metaltronica SpA.
Which region commanded the largest share of the Global Mammography Systems Market in 2024?
North America commanded the largest regional share of 34.5% in 2024, supported by advanced infrastructure, strong reimbursement policies, and high adoption of digital mammography.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
The Cuffless Blood Pressure Monitor Market size was valued at USD 414.8 million in 2024 and is anticipated to reach USD 980.27 million by 2032, growing at a CAGR of 9.2% during the forecast period.
The global Dental Digital X-ray market was valued at USD 3.45 billion in 2024 and is projected to reach USD 4.83 billion by 2032, registering a CAGR of 4.3% during the forecast period.
Dental Lights Market size was valued at USD 830.64 million in 2024 and is anticipated to reach USD 1,236.61 million by 2032, at a CAGR of 5.1% during the forecast period.
Critical Care Devices Market size was valued USD 12.5 billion in 2024 and is anticipated to reach USD 22.8 billion by 2032, at a CAGR of 7.8% during the forecast period.
Critical Care Diagnostics Market size was valued at USD 6.8 Billion in 2024 and is anticipated to reach USD 13.06 Billion by 2032, at a CAGR of 8.5% during the forecast period.
CT Scanner Market size was valued at USD 6.8 billion in 2024 and is anticipated to reach USD 8.75 billion by 2032, at a CAGR of 3.2% during the forecast period.
The Germany Cardiovascular Devices Market size was valued at USD 2,390.46 million in 2018, increased to USD 3,958.68 million in 2024, and is anticipated to reach USD 7,368.98 million by 2032, at a CAGR of 7.52% during the forecast period.
The 3D Cell Culture Microplates Market was valued at USD 1,021.61 million in 2018, grew to USD 1,762.52 million in 2024, and is anticipated to reach USD 3,826.18 million by 2032, expanding at a CAGR of 9.48% during the forecast period.
The Global Wound Closure Surgical Products market size was valued at USD 9,211.4 million in 2018 and reached USD 14,165.9 million in 2024. It is anticipated to reach USD 23,105.2 million by 2032, growing at a CAGR of 6.26% during the forecast period.
The Global Wound Debridement Products market size was valued at USD 3,239.9 million in 2018 and increased to USD 4,515.9 million in 2024. It is anticipated to reach USD 7,103.1 million by 2032, growing at a CAGR of 5.85% during the forecast period.
Orthopedic Imaging Equipment Market size was valued USD 3.2 Billion in 2024 and is anticipated to reach USD 5.38 Billion by 2032, at a CAGR of 6.7% during the forecast period.
The orthopedic braces and support market size was valued at USD 3.84 billion in 2024 and is anticipated to reach USD 6.1 billion by 2032, at a CAGR of 5.96% during the forecast period.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$6999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
